Medpace Holdings, Inc. MEDP NASDAQ

Medpace Holdings, Inc. (MEDP) generated $713.22M in operating cash flow for fiscal year 2025. After capital expenditures of $31.36M, free cash flow was $681.87M.

Free cash flow margin was 26.9% of revenue. Cash conversion ratio was 1.58x, indicating earnings are backed by cash.

The company returned $917.39M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (62/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (70/100) — Cash conversion ratio was 1.58x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.